United States - English - NLM (National Library of Medicine)

betco corporation, ltd. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - - ​ ​antibacterial hand cleaner. - use in daycare, hospitals, nursing homes, physicians offices, dental offices and clinics antibacterial

United States - English - NLM (National Library of Medicine)

betco corporation, ltd. - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - uses - ​ ​antibacterial skin cleanser. - use in a variety of public facilities including daycare centers, hospitals, nursing homes, physicians offices. purpose antibacterial

United States - English - NLM (National Library of Medicine)

betco corporation, ltd. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - antibacterial - ​ ​antibacterial hand cleanser. - use in daycare centers, hospitals, nursing homes, physician offices, dental offices and clinics. antibacterial - antibacterial skin cleanser. - use in daycare centers, hospitals, nursing homes, physician offices, dental offices, and clinics. antibacterial - antibacterial skin cleanser - use in daycare centers, hospitals, nursing homes, physician offices, dental offices and clinics.

United States - English - NLM (National Library of Medicine)

kaplan distribution llc - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - antibacterial wet wipes. antibacterial wet wipes. cleans and softens the skin and provides a pleasant odor. do not use on eyes.

United States - English - NLM (National Library of Medicine)

r & r lotion, inc - benzalkonium chloride 0.13% - antibacterial for handwashing to decrease bacteria on the skin

United States - English - NLM (National Library of Medicine)

wg critical care, llc - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - ceftriaxone 500 mg - before instituting treatment with ceftriaxone for injection, usp, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection, usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused

United States - English - NLM (National Library of Medicine)

wockhardt limited - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - ceftriaxone 250 mg - before instituting treatment with ceftriaxone for injection, usp appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection, usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused b

United States - English - NLM (National Library of Medicine)

wockhardt usa llc. - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - ceftriaxone 250 mg - before instituting treatment with ceftriaxone for injection, usp appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection, usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused b

Australia - English - Department of Health (Therapeutic Goods Administration)

ego pharmaceuticals pty ltd - ethanol, quantity: 73.76 % w/w (equivalent: ethanol absolute, qty 70 % w/w) - gel - excipient ingredients: purified water; 2-amino-2-methyl-1-propanol; glycerol; dexpanthenol; acrylates/c10-30 alkyl acrylate crosspolymer; fragrance (perfume) - antibacterial and antiseptic hand sanitiser. helps reduce bacteria that can potentially cause disease.

United States - English - NLM (National Library of Medicine)

wg critical care, llc - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - before instituting treatment with ceftriaxone for injection, usp, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection, usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused